XPH vs. DBO
XPH (SPDR S&P Pharmaceuticals ETF) and DBO (Invesco DB Oil Fund) are both exchange-traded funds - XPH is a Health & Biotech Equities fund tracking the S&P Pharmaceuticals Select Industry Index, while DBO is a Oil & Gas fund tracking the DBIQ Optimum Yield Crude Oil Index Excess Return. Both are passively managed. Over the past 10 years, XPH returned 4.80%/yr vs 11.43%/yr for DBO. Their 0.17 correlation means their historical movements had little consistent relationship. XPH charges 0.35%/yr vs 0.78%/yr for DBO.
Performance
XPH vs. DBO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XPH achieves a 22.08% return, which is significantly lower than DBO's 66.72% return. Over the past 10 years, XPH has underperformed DBO with an annualized return of 4.80%, while DBO has yielded a comparatively higher 11.43% annualized return.
XPH
- 1D
- 0.25%
- 1M
- 1.59%
- 6M
- 19.87%
- YTD
- 22.08%
- 1Y
- 64.62%
- 3Y*
- 17.93%
- 5Y*
- 7.45%
- 10Y*
- 4.80%
- ALL TIME*
- 9.39%
DBO
- 1D
- -5.53%
- 1M
- 17.71%
- 6M
- 53.16%
- YTD
- 66.72%
- 1Y
- 51.44%
- 3Y*
- 12.33%
- 5Y*
- 13.64%
- 10Y*
- 11.43%
- ALL TIME*
- 0.22%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $11.34M | $10.71M | $13.49M | |
| $7.06M | $7.70M | $5.53M |
XPH vs. DBO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 22.08% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 25.61% | -15.32% | 12.05% |
DBO Invesco DB Oil Fund | 66.72% | -11.71% | 7.85% | -4.44% | 13.04% | 60.74% | -20.99% | 28.05% | -15.22% | 4.86% |
Correlation
The correlation between XPH and DBO is -0.25, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.25 |
Correlation (3Y) Balances recent behavior with more history. | -0.11 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.00 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.11 |
Correlation (All Time) Calculated using the full available price history since Jan 5, 2007 | 0.17 |
The correlation between XPH and DBO shifts across timeframes, from -0.25 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XPH vs. DBO — Risk / Return Rank
XPH
DBO
XPH vs. DBO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and Invesco DB Oil Fund (DBO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XPH | DBO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.55 | ||
| Sortino ratioReturn per unit of downside risk | +1.85 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 1.23 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 5.43 | 1.86 | +3.56 |
| Martin ratioReturn relative to average drawdown | 19.31 | 5.64 | +13.66 |
Loading charts...
Drawdowns
XPH vs. DBO - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, smaller than the maximum DBO drawdown of -90.18%. Use the drawdown chart below to compare losses from any high point for XPH and DBO.
Loading charts...
Drawdown Indicators
| XPH | DBO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -90.18% | +42.15% |
Max Drawdown (1Y)Largest decline over 1 year | -11.97% | -27.73% | +15.76% |
Max Drawdown (3Y)Largest decline over 3 years | -23.57% | -28.20% | +4.63% |
Max Drawdown (5Y)Largest decline over 5 years | -30.92% | -37.68% | +6.76% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | -61.69% | +25.72% |
Current DrawdownCurrent decline from peak | -2.60% | -56.13% | +53.53% |
Average DrawdownAverage peak-to-trough decline | -17.12% | -62.20% | +45.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.36% | 9.16% | -5.80% |
Volatility
XPH vs. DBO - Volatility Comparison
The current volatility for SPDR S&P Pharmaceuticals ETF (XPH) is 7.62%, while Invesco DB Oil Fund (DBO) has a volatility of 18.99%. This indicates that XPH experiences smaller price fluctuations and is considered to be less risky than DBO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XPH | DBO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.62% | 18.99% | -11.37% |
Volatility (6M)Calculated over the trailing 6-month period | 17.53% | 34.30% | -16.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.59% | 38.86% | -16.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.02% | 33.43% | -12.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.14% | 32.24% | -10.10% |
XPH vs. DBO - Expense Ratio Comparison
XPH has a 0.35% expense ratio, which is lower than DBO's 0.78% expense ratio.
Dividends
XPH vs. DBO - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.49%, less than DBO's 2.11% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DBO Invesco DB Oil Fund | 2.11% | 3.51% | 4.68% | 4.59% | 0.66% | 0.00% | 0.00% | 1.63% | 1.58% | 0.00% | 0.00% | 0.00% |
XPH SPDR S&P Pharmaceuticals ETF | 0.49% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
XPH and DBO have a correlation of -0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DBO has higher volatility (18.99%) compared to XPH (7.62%). In terms of maximum drawdown, XPH dropped -48.03% vs DBO's -90.18%.
On 10-year performance, DBO leads with 11.43% vs 4.80% for XPH. On fees, XPH is cheaper at 0.35% per year. On volatility, XPH has been the lower-risk option at 7.62%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, DBO has performed better with a 11.43% return vs 4.80%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XPH is cheaper with a 0.35% expense ratio, compared with 0.78% for DBO.
DBO has the higher dividend yield at 2.11%, compared with 0.49% for XPH.
XPH is categorized as Health & Biotech Equities, while DBO is Oil & Gas. XPH tracks S&P Pharmaceuticals Select Industry Index, while DBO tracks DBIQ Optimum Yield Crude Oil Index Excess Return. They also come from different issuers: State Street and Invesco. Their fees differ too: 0.35% for XPH and 0.78% for DBO.
XPH currently has the higher Sharpe Ratio (2.88 vs 1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XPH and DBO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer